South and Central America Anaphylaxis Treatment Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Medication Type (Epinephrine, Antihistamines, Steroids, Beta-Agonist, and Others), Route of Administration (Oral, Parenteral, and Others), Allergy Type (Food Allergy, Medications, Insect Stings, and Others) and Distribution Channel (Hospital Pharmacies, Retail Sales, and Others)

No. of Pages: 136
Report Code: TIPRE00023955
Category: Life Sciences
South and Central America Anaphylaxis Treatment Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. South and Central America Anaphylaxis Treatment Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. South and Central America Anaphylaxis Treatment Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. South and Central America Anaphylaxis Treatment Market Regional Analysis

6.2 South and Central America Anaphylaxis Treatment Market Revenue 2019-2028 (US$ Million)
6.3 South and Central America Anaphylaxis Treatment Market Forecast Analysis

7. South and Central America Anaphylaxis Treatment Market Analysis – by Medication Type

7.1 Epinephrine
  • 7.1.1 Overview
  • 7.1.2 Epinephrine: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Antihistamines
  • 7.2.1 Overview
  • 7.2.2 Antihistamines: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Steroids
  • 7.3.1 Overview
  • 7.3.2 Steroids: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Beta-Agonist
  • 7.4.1 Overview
  • 7.4.2 Beta-Agonist: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. South and Central America Anaphylaxis Treatment Market Analysis – by Route of Administration

8.1 Oral
  • 8.1.1 Overview
  • 8.1.2 Oral: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Parenteral
  • 8.2.1 Overview
  • 8.2.2 Parenteral: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. South and Central America Anaphylaxis Treatment Market Analysis – by Allergy Type

9.1 Food Allergy
  • 9.1.1 Overview
  • 9.1.2 Food Allergy: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Medications
  • 9.2.1 Overview
  • 9.2.2 Medications: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Insect Stings
  • 9.3.1 Overview
  • 9.3.2 Insect Stings: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. South and Central America Anaphylaxis Treatment Market Analysis – by Distribution Channel

10.1 Hospital Pharmacies
  • 10.1.1 Overview
  • 10.1.2 Hospital Pharmacies: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Retail Sales
  • 10.2.1 Overview
  • 10.2.2 Retail Sales: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. South and Central America Anaphylaxis Treatment Market – South and Central America Analysis

11.1 Overview

11.2 South and Central America
  • 11.2.1 South and Central America Anaphylaxis Treatment Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 11.2.1.1 South and Central America Anaphylaxis Treatment Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 Brazil: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.1.1 Brazil: South and Central America Anaphylaxis Treatment Market Breakdown, by Medication Type
    • 11.2.1.1.2 Brazil: South and Central America Anaphylaxis Treatment Market Breakdown, by Route of Administration
    • 11.2.1.1.3 Brazil: South and Central America Anaphylaxis Treatment Market Breakdown, by Allergy Type
    • 11.2.1.1.4 Brazil: South and Central America Anaphylaxis Treatment Market Breakdown, by Distribution Channel
  • 11.2.1.2 Argentina: South and Central America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.2.1 Argentina: South and Central America Anaphylaxis Treatment Market Breakdown, by Medication Type
    • 11.2.1.2.2 Argentina: South and Central America Anaphylaxis Treatment Market Breakdown, by Route of Administration
    • 11.2.1.2.3 Argentina: South and Central America Anaphylaxis Treatment Market Breakdown, by Allergy Type
    • 11.2.1.2.4 Argentina: South and Central America Anaphylaxis Treatment Market Breakdown, by Distribution Channel
  • 11.2.1.3 Rest of South and Central America : South and Central America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.3.1 Rest of South and Central America : South and Central America Anaphylaxis Treatment Market Breakdown, by Medication Type
    • 11.2.1.3.2 Rest of South and Central America : South and Central America Anaphylaxis Treatment Market Breakdown, by Route of Administration
    • 11.2.1.3.3 Rest of South and Central America : South and Central America Anaphylaxis Treatment Market Breakdown, by Allergy Type
    • 11.2.1.3.4 Rest of South and Central America : South and Central America Anaphylaxis Treatment Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 Amneal Pharmaceuticals Inc.
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 Mylan N.V.
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 Abbott
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 Pfizer Inc.
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 Glaxosmithkline Plc.,
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 Merck And Co., Inc.
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 Teva Pharmaceutical Industries Ltd.
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 ALK-ABELLó
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - South and Central America Anaphylaxis Treatment Market

  • Amneal Pharmaceuticals Inc.
  • Mylan N.V.
  • Abbott
  • Pfizer Inc.
  • Glaxosmithkline Plc.,
  • Merck And Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • ALK-ABELLó
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)